Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Bullboard Posts
Post by MetzGERon Mar 12, 2020 2:39am
174 Views
Post# 30797317

Light to alopecia? Increased hair with cell transplant

Light to alopecia? Increased hair with cell transplanthttps://www.asahi.com/articles/ASN394WMDN36ULBJ00R.html?iref=sp_nattop_feature_list_n


 

 
[PR]

After culturing the cells of my own hair and transplanting it to the scalp, the hair "regenerated"-. Such results have been announced by research teams such as Tokyo Medical University. May lead to treatments that improve alopecia and thinning hair.

Age-related alopecia is the most common among alopecia and has a significant impact on quality of life (QOL). It is said that there are many treatments in Japan in Japan, but there are problems such as continuous progress and limited options for women.

Ryoji Tsuboi, professor of dermatology at Tokyo Medical University, has been working with Toho University and Shiseido to study how to stimulate hair growth by transplanting cells that activate hair-making activities into the scalp.

For 50 males and 15 females, the scalp of the occipital region is taken from each, and special cells in the hair root are taken out and cultured. The scalp was injected to see how much hair had "regenerated" in one year.

As a result, the effect of increasing and thickening the hair was confirmed in the area where the cells were implanted, compared to the area where the cell-free solution was injected, and the hair was increased by up to about 8%. Tsuboi says, "The results have been sufficiently responsive to show that it can be a new treatment." (Masayoshi Toda)


 

 
[PR]

After culturing the cells of my own hair and transplanting it to the scalp, the hair "regenerated"-. Such results have been announced by research teams such as Tokyo Medical University. May lead to treatments that improve alopecia and thinning hair.

Age-related alopecia is the most common among alopecia and has a significant impact on quality of life (QOL). It is said that there are many treatments in Japan in Japan, but there are problems such as continuous progress and limited options for women.

Ryoji Tsuboi, professor of dermatology at Tokyo Medical University, has been working with Toho University and Shiseido to study how to stimulate hair growth by transplanting cells that activate hair-making activities into the scalp.

For 50 males and 15 females, the scalp of the occipital region is taken from each, and special cells in the hair root are taken out and cultured. The scalp was injected to see how much hair had "regenerated" in one year.

As a result, the effect of increasing and thickening the hair was confirmed in the area where the cells were implanted, compared to the area where the cell-free solution was injected, and the hair was increased by up to about 8%. Tsuboi says, "The results have been sufficiently responsive to show that it can be a new treatment." (Masayoshi Toda)


Bullboard Posts